ATC Group: J06BA02 Immunoglobulins, normal human, for intravascular adm.

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J06BA02 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J06 Immune sera and immunoglobulins
3 J06B Immunoglobulins
4 J06BA Immunoglobulins, normal human
5 J06BA02 Immunoglobulins, normal human, for intravascular adm.

Active ingredients in J06BA02

Active Ingredient Description
Immunoglobulins, normal human, IV

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects.

Related product monographs

Title Information Source Document Type  
FLEBOGAMMA DIF Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GAMMAPLEX Solution for infusion FDA, National Drug Code (US) MPI, US: SPL/PLR
GAMUNEX Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GAMUNEX-C Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
INTRAGAM Solution for infusion Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
KIOVIG Solution for infusion European Medicines Agency (EU) MPI, EU: SmPC
PANZYGA Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

Japan (JP)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.